Whitepaper
15 Sep 2021

Biological Solutions

PDF 2.2 MB

Dedicated primary packaging for biological active ingredients : from reduced silicone- , and polymer syringes over ready-to-fill glass- and COP vials to customized product developments  and much more.


Content provided by our supplier

Gerresheimer AG

  • DE
  • 2015
    On CPHI since
  • 2
    Certificates
  • 5000+
    Employees
Company types
CMO/CDMO
Contract Service
Manufacturer/Innovator
Packaging supplier/manufacturer
Primary activities
Animal Health
Biopharmaceutical
Contract Manufacturer
Medical Devices
Packaging & drug delivery

Other Content from Gerresheimer AG (11)

  • News Gerresheimer predicts weight-loss drug deals to account for 4% of yearly growth

    Dietmar Siemssen, CEO of German primary packaging manufacturer Gerresheimer, states that approximately 4% of the company’s revenue growth each year to come from deals with drugmakers of weight loss and diabetes products, particularly GLP-1 class drugs. 
  • Brochure Primary Packaging Plastics - Solid dosages

    Gerresheimer Primary Packaging Plastics specializesin the widely varied spectrum of pharmaceuticalplastic packaging within solid, liquid andophthalmic applications, plastic vials and plasticbottles for personal care.
  • Webinar Gerresheimer's Product Platforms: Designated Quality Levels to Secure Best in Class Performance in Multiple Application Fields & Demanding Disease Areas

    "As a solution provider with a unique & dedicated product portfolio​, Gerresheimer is continuously exploring options to better accommodate their customers along the drug development and drug LCM journey. With its newly installed product platforms, Gerresheimer will be combining outstanding quality levels with specific product requirements in dedicated application fields and disease areas. From dental care over hematology, vaccines, diabetes and metabolism disorders into complex and more demanding areas such as Cell Gene Therapy, ophthalmology and oncology ... Gerresheimer will be able to support even better in finding the best containment solution for their specific application. Picking one example, we'll elaborate on our offering in the ophthalmology field ..."
  • Webinar Sensory Exploration: A Journey into Patient-Centric Perception

    From sight, touch, taste, and smell to hearing, the five senses allow the body to take everything in. Research shows that the more senses are used, the better the memory is gathered, and the process enhanced. How does this theory apply to device development, design conception, and patient experience?
  • Webinar Lightning Talk - Opportunities and Challenges in Connected Drug Delivery

    The talk explores the current integration of digital health in drug delivery and various opportunities that it presents. Delving into the landscape of drug delivery, we examine the rise of connected devices, emphasizing the delicate balance between technology and compassionate care. This session also addresses real-world challenges like adoption, satisfaction, regulatory, and security considerations. Be part of the conversation on overcoming these challenges.
  • Webinar Partner Presentation - Gerresheimer

    Overcoming challenges when developing subcutaneous drug delivery devices that empower patient self-administration. The trend in parenteral patient therapy has been moving towards the home-care setting for some time as it empowers patient independence. However, home administration brings additional requirements when developing a delivery device, and these are constantly evolving. Patient safety is always paramount, but usability is another critical factor, as well as sustainability and connectivity to support patient adherence. The challenge is to design a device to meet as many requirements as possible that can be ready on the market within 4-8 years. In this presentation we will discuss Gerresheimer’s mission of “innovating for a better life” and how we apply this when developing solutions that respond to the needs of patients, our pharmaceutical industry customers, and the environment, today and into the future.
  • Webinar Lightning Talk - Next-Gen Wearable Devices

    Wearables can take different shapes and sizes and are revolutionizing the way we monitor, treat, and manage health conditions. In this short deep dive, we will look at innovative wearable technologies and how they enable data collection and analysis, patient centric care, personalized medicine and more.
  • Webinar Lightning Talk - Blister Packs - How is the Past shaping the Future?

    What are blister packs, and why are they so important? How have they changed over the years, and where are they heading? This presentation will consider a history of how blister packs have benefitted the supply of medicines to patients worldwide, and how they are continuing to evolve within an increasingly sustainable landscape.
  • Webinar Keynote Address

    How can device and packaging innovation influence patient ability and motivation to use their treatment?" With examples from research of how patients learn and become motivated, and how industry can use these processes to influence patient outcomes. Patients learn through a mixture of stimuli and learning processes, these stimuli can be adopted into device design and packaging to enhance the patient's feelings about their medication. Presently many patients using complex devices, like inhalers, make critical errors which entails repeated re-training. This presentation looks at innovative ways of embedding learning, that could be adopted by future device and packaging design.